Starting on:
May 11, 2020
Ending on:
Jul 1, 2020
Moderator(s):
Venue:
Virtual- International Cancer Institute
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
May 11, 2020
Ending on:
Jul 1, 2020
Moderator(s):
Virtual- International Cancer Institute
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
INTERNATIONAL CANCER INSTITUTE SICKLE CELL DISEASE PRECEPTORSHIP
Starting on:
May 11, 2020 4:00 PM
May 11, 2020 4:00 PM
Ending on:
Jul 1, 2020 5:00 PM
Jul 1, 2020 5:00 PM
Venue:
Virtual- International Cancer Institute
Virtual- International Cancer Institute
Description
Multidisciplinary management, standards of care, optimal diagnostics, therapies and future perspectives in the care of Sickle Cell patients in sub-Saharan Africa. The primary target audience for this course comprise the multidisciplinary clinical Sickle Cell care team members including, but not limited to physicians; fellows; residents; researchers; SCD nurse practitioners and SCD nurses; SCD pharmacists; SCD PharmTechs; SCD clinical officers; physician assistants; Laboratory scientists and technicians and other allied health care professionals.
Objectives
At the end of this educational activity, participants should be able to:
1. Describe the epidemiology, molecular basis, presentation and natural history of SCD and the variant sickle cell syndromes
2. Describe the techniques for Screening and the diagnosis of SCD; Correctly interpret electrophoresis and HPLC traces
3. Understand the pathophysiology and clinical manifestations of sickle cell disease: acute pain crises and progressive organ damage.
4. Describe the management of specific major acute complications, including the acute chest syndrome, painful crisis, stroke etc
5. Describe the long-term complications of SCD (including orthopaedic, ophthalmic, renal, pulmonary, endocrine and fertility issues) and their management, in particular the need for comprehensive multi-disciplinary care
6. Understand the use of disease modifying agents in the management of SCD
7. Understand gene therapy, stem cell transplant and novel therapies in SCD treatment
8. Explain appropriate use of transfusion in SCD
9. Describe the complications, assessment and treatment of transfusional iron overload
10. Demonstrate a working knowledge and practical competency for acute and chronic pain management in patients with sickle cell disease.
11. Design a Health maintenance program for Pediatrics, Adolescents and Young Adults with SCD
Presenters
-
Dr.
Festus Njuguna
Pediatrician (Hematology/Oncology)
Moi University -
Prof.
Anne Greist
Hematologist and Medical Oncologist
Indiana Hemophilia and Thrombosis Center -
Prof.
Anne Greist
Hematologist and Medical Oncologist
Indiana Hemophilia and Thrombosis Center -
Prof.
Riyat Malkit
Consultant Hematologist
Aga Khan University Hospital -
Prof.
Fredrick Chite
Consultant Physician. Medical Oncologist & Hematologist Executive Director/CEO
International Cancer Institute (ICI) -
Prof.
Anne Greist
Hematologist and Medical Oncologist
Indiana Hemophilia and Thrombosis Center -
Prof.
Anne Greist
Hematologist and Medical Oncologist
Indiana Hemophilia and Thrombosis Center -
Prof.
Riyat Malkit
Consultant Hematologist
Aga Khan University Hospital -
Prof.
Fredrick Chite
Consultant Physician. Medical Oncologist & Hematologist Executive Director/CEO:
International Cancer Institute (ICI) -
Dr.
Zipporah Ali
Executive Director
Kenya Hospices and Palliative Care Association (KEHPCA) -
Prof.
Fredrick Chite
Consultant Physician. Medical Oncologist & Hematologist Executive Director/CEO:
International Cancer Institute (ICI) -
Miss
Catherine Wangechi
Clinical Psychologist
-
Prof.
Riyat Malkit
Consultant Hematologist
Aga Khan University Hospital